In my opinion it is not unrealistic, but having a CVR for a significant amount of Billions of dollars I believe does not give great optics to the BP acquiring Amarin. So I would imagine that if Amarin can secure an expedited ruling and expect resolution within 3-4 months after summer, it is more plausible that a BO waits for clarity. However if the resolution is expected next year, the European market needs work to get it started, so I don't think that they would wait and a CVR then would be more likely.
Remember Inhibitex? Woke up one day to a buyout.Anti-inflammatory drugs like Vascepa Maybe they will be a hot commodity with covid-19,and plenty more diseases to come resulting from animal-based diets
News 
Market Data 
Discover 
